Epigenetics

Syndicate content
Google News
Updated: 14 hours 40 min ago

Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11 - Associated Press

Thu, 2019-03-07 16:48
Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11  Associated Press

This *content* is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

Does extreme weather cause stress in unborn children? - WZZM13.com

Thu, 2019-03-07 14:25
Does extreme weather cause stress in unborn children?  WZZM13.com

A new study concludes higher distress rates in offspring affected by severe weather while developing, but doctors are not so fast to agree.

Top News in Neurology March 07 2019 (9 of 12) - MD Linx

Thu, 2019-03-07 12:28
Top News in Neurology March 07 2019 (9 of 12)  MD Linx

Studies into the heritability of insomnia go back over half a century. Recent research points the finger at hundreds of genes, yet they can only explain part of the ...

2018 Global Epigenetics Market Share, Analysis, Research by Top Companies, Topmost Regions, Product type, Application, Forecast 2023 - The Paramount Daily

Thu, 2019-03-07 11:34
2018 Global Epigenetics Market Share, Analysis, Research by Top Companies, Topmost Regions, Product type, Application, Forecast 2023  The Paramount Daily

Epigenetics Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in ...

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 09:20
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 09:20
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 09:20
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 09:20
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

Ovarian Cancer Project Gathers Industry Support Labmate Online - Labmate Online

Thu, 2019-03-07 04:45
Ovarian Cancer Project Gathers Industry Support Labmate Online  Labmate Online

A new £2.6 million project led by Swansea University (UK) that aims to dramatically improve the diagnosis and treatment of ovarian cancer, will involve ...

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11 - GlobeNewswire

Thu, 2019-03-07 02:00
Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11  GlobeNewswire

MINNEAPOLIS, March 07, 2019 (GLOBE NEWSWIRE) -- Life Epigenetics, a biotechnology company that discovers, quantifies and commercializes epigenetic ...

An epigenetic marker can predict survival in childhood leukaemia - Medical Xpress

Thu, 2019-03-07 02:00
An epigenetic marker can predict survival in childhood leukaemia  Medical Xpress

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis.

Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock - Associated Press

Wed, 2019-03-06 22:06
Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock  Associated Press

This *content* is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.